Details for New Drug Application (NDA): 214267
✉ Email this page to a colleague
The generic ingredient in LIDOCAINE HYDROCHLORIDE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 214267
Tradename: | LIDOCAINE HYDROCHLORIDE |
Applicant: | Sintetica Us |
Ingredient: | lidocaine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 214267
Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 214267
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 214267 | ANDA | SINTETICA SA | 68055-641 | 68055-641-10 | 10 AMPULE in 1 CARTON (68055-641-10) / 2 mL in 1 AMPULE (68055-641-01) |
LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 214267 | ANDA | SINTETICA SA | 68055-642 | 68055-642-10 | 10 AMPULE in 1 CARTON (68055-642-10) / 5 mL in 1 AMPULE (68055-642-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1% | ||||
Approval Date: | Sep 19, 2022 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2% | ||||
Approval Date: | Sep 19, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription